TXMD
TXMD clinical trials: TherapeuticsMD, Inc.
Every trial on ClinicalTrials.gov where TherapeuticsMD, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 6
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
TXMD on the catalyst calendar · TXMD registry changes
- Primary completion Jun 8, 2021ActualPhase 1NCT04272008The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl EstradiolTherapeuticsMD · ContraceptionCompletedTXMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 6, 2021ActualPhase 1NCT04290390Annovera™ Drug-Drug Interaction StudyTherapeuticsMD · WomenCompletedTXMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 28, 2016ActualPhase 3NCT01942668A Safety and Efficacy Study of the Combination Estradiol and Progesterone to Treat Vasomotor SymptomsTherapeuticsMD · MenopauseCompletedTXMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 31, 2014ActualPhase 3NCT02019589A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium...TherapeuticsMD · Secondary AmenorrheaTerminatedTXMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2015ActualPhase 3NCT02253173Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal WomenTherapeuticsMD · Vulvovaginal AtrophyCompletedTXMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2013ActualPhase 2NCT02449902TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal AtrophyTherapeuticsMD · MenopauseCompletedTXMDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2018ActualPhase 3NCT02224313Effect of Oral Estradiol and Progesterone Therapy on Vaginal Cytokines in Postmenopausal WomenIntira Sriprasert · MenopauseCompletedTXMDCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner